Zhou Kaina, Wang Duolao, Li Hengxin, Wei Xiaoli, Yin Juan, Liang Peifeng, Kou Lingling, Hao Mengmeng, You Lijuan, Li Xiaomei, Zhuang Guihua
Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom.
PLoS One. 2017 Jun 6;12(6):e0179009. doi: 10.1371/journal.pone.0179009. eCollection 2017.
This study aimed to explore the bidirectional relationships between retention and health-related quality of life (HRQoL) in patients from mainland China receiving methadone maintenance treatment (MMT). This prospective cohort study recruited 1,212 eligible MMT patients from the two largest MMT clinics (one privately and another publicly funded) in Xi'an. This study started in March 2012 with a 2-year follow-up until March 2014. Retention was assessed by repeated terminations, past treatment duration, premature terminations, and follow-up treatment duration. HRQoL was evaluated using the Chinese (simple) short-form 36 health survey version 2 (SF-36v2) and the quality of life scale for drug addicts (QOL-DAv2.0). Linear and Cox regression analyses were used to explore relationships between retention and HRQoL. A general linear model was used to further examine the global effect of past treatment duration on HRQoL. Multivariate analyses showed that repeated terminations had no significant impact on HRQoL scores in MMT patients; however, past treatment time (year) influenced the SF-36v2PCS (P = 0.004): treatment for ≥4 years showed a lower SF-36v2PCS score (regression coefficient: -2.39; 95% confidence interval [CI]: -3.80, -0.97; P = 0.001) than treatment for <1 year. In addition, patients with an SF-36v2PCS score > 49 (hazard ratio: 0.83; 95% CI: 0.69, 0.98; P = 0.03) were 17% less likely to terminate MMT than those with scores of ≤49. In conclusion, retention and HRQoL tended to have a bidirectional relationship, which should be considered in the development of retention and health-management programs for patients with MMT.
本研究旨在探讨中国大陆接受美沙酮维持治疗(MMT)的患者中,治疗留存率与健康相关生活质量(HRQoL)之间的双向关系。这项前瞻性队列研究从西安两家最大的MMT诊所(一家私立,一家公立)招募了1212名符合条件的MMT患者。本研究于2012年3月开始,进行为期2年的随访,直至2014年3月。通过重复终止治疗、既往治疗时长、提前终止治疗和随访治疗时长来评估治疗留存率。使用中文版(简化版)36项简短健康调查问卷第2版(SF-36v2)和吸毒者生活质量量表(QOL-DAv2.0)评估HRQoL。采用线性回归和Cox回归分析来探讨治疗留存率与HRQoL之间的关系。使用一般线性模型进一步检验既往治疗时长对HRQoL的总体影响。多变量分析显示,重复终止治疗对MMT患者的HRQoL评分没有显著影响;然而,既往治疗时间(年)影响SF-36v2生理健康综合评分(PCS)(P = 0.004):治疗≥4年的患者SF-36v2 PCS评分低于治疗<1年的患者(回归系数:-2.39;95%置信区间[CI]:-3.80,-0.97;P = 0.001)。此外,SF-36v2 PCS评分>49的患者(风险比:0.83;95% CI:0.69,0.98;P = 0.03)终止MMT治疗的可能性比评分≤49的患者低17%。总之,治疗留存率与HRQoL之间倾向于存在双向关系,在制定MMT患者的治疗留存和健康管理计划时应予以考虑。